- Home
- HOWL vs CCLD Comparison
HOWL vs CCLD Comparison
Compare HOWL & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- CCLD
- Stock Information
- Founded
- HOWL 2017
- CCLD 1999
- Country
- HOWL United States
- CCLD United States
- Employees
- HOWL N/A
- CCLD N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- HOWL Health Care
- CCLD Technology
- Exchange
- HOWL Nasdaq
- CCLD Nasdaq
- Market Cap
- HOWL 37.9M
- CCLD 52.5M
- IPO Year
- HOWL 2021
- CCLD 2014
- Fundamental
- Price
- HOWL $0.87
- CCLD $1.84
- Analyst Decision
- HOWL Strong Buy
- CCLD Buy
- Analyst Count
- HOWL 3
- CCLD 2
- Target Price
- HOWL $9.00
- CCLD $3.00
- AVG Volume (30 Days)
- HOWL 232.7K
- CCLD 685.2K
- Earning Date
- HOWL 05-08-2025
- CCLD 05-06-2025
- Dividend Yield
- HOWL N/A
- CCLD N/A
- EPS Growth
- HOWL N/A
- CCLD N/A
- EPS
- HOWL N/A
- CCLD N/A
- Revenue
- HOWL $1,143,000.00
- CCLD $112,507,000.00
- Revenue This Year
- HOWL N/A
- CCLD $3.18
- Revenue Next Year
- HOWL $733.33
- CCLD $5.81
- P/E Ratio
- HOWL N/A
- CCLD N/A
- Revenue Growth
- HOWL N/A
- CCLD N/A
- 52 Week Low
- HOWL $0.60
- CCLD $1.04
- 52 Week High
- HOWL $6.34
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- HOWL 46.85
- CCLD 54.01
- Support Level
- HOWL $0.80
- CCLD $1.73
- Resistance Level
- HOWL $0.97
- CCLD $2.44
- Average True Range (ATR)
- HOWL 0.07
- CCLD 0.18
- MACD
- HOWL 0.02
- CCLD 0.06
- Stochastic Oscillator
- HOWL 41.92
- CCLD 45.95
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.